| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 04/25/2007 | CN1311870C Interleukin 6 production inhibitor |
| 04/25/2007 | CN1311849C Medicinal composition for treating swelling paint |
| 04/25/2007 | CN1311829C Heteroaryl compounds which inhibit leukocyte adhesion mediated by alpha-4 integrins |
| 04/25/2007 | CN1311806C Oral liquor preparation contg. radix bupleuri, and its prepn. method |
| 04/24/2007 | US7208629 5′-Carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2007 | US7208582 Polynucleotides codes for antibodies having amino acid sequences selected from complementary determining regions of variable peptides or single chain fragments, used as anticarcinogenic agents |
| 04/24/2007 | US7208513 Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith |
| 04/24/2007 | US7208498 Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 04/24/2007 | US7208489 2-(pyridin-2-ylamino)-pyrido [2,3-d]pyrimidin-7-ones |
| 04/24/2007 | US7208466 Treating pain or inflammation; inhibiting C-fibre neuron activity; hemagglutinins conjugated with protein |
| 04/24/2007 | US7208279 Method for identifying inhibitors of G protein coupled receptor signaling |
| 04/24/2007 | US7208166 Use of botuline toxin to obtain a product to be used in articular pathologies, particularly coxarthrosis, epicondylitis and rotator muscle cap pathology |
| 04/24/2007 | US7208150 Non-toxic fraction isolated from the venom of Vipera xanthina, for therapy of pain |
| 04/24/2007 | US7208149 IL-16 antagonist peptides and DNA encoding the peptides |
| 04/24/2007 | CA2410852C 1-amino-alkylcyclohexanes as 5-ht3 and neuronal nicotinic receptor antagonists |
| 04/24/2007 | CA2289574C 8-azabicyclo(3,2,1)oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ach receptors |
| 04/24/2007 | CA2281545C N-heterocyclic derivatives as nos inhibitors |
| 04/24/2007 | CA2268741C Uses of keratinocyte growth factor-2 |
| 04/24/2007 | CA2234610C New amino acid derivatives, processes for preparing them and pharmaceutical compositions containing these compounds |
| 04/24/2007 | CA2131644C Quinoline compounds |
| 04/19/2007 | WO2007043710A1 Novel dihydropseudoerythromycin derivatives |
| 04/19/2007 | WO2007043652A1 2-thienylurea derivative |
| 04/19/2007 | WO2007043581A1 Thienopyridine-2-carboxamide derivative |
| 04/19/2007 | WO2007043580A1 Iontophoresis preparation for treatment of breast cancer and/or mastitis |
| 04/19/2007 | WO2007043426A1 Dermatitis remedies |
| 04/19/2007 | WO2007043401A1 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same |
| 04/19/2007 | WO2007043400A1 Nitrogenated aromatic heterocyclic compound and pharmaceutical composition comprising the same |
| 04/19/2007 | WO2007042983A2 Fluridone as an anti-inflammatory agent |
| 04/19/2007 | WO2007042817A1 Naphthalene-disulfonamides useful for the treatment of inflammation |
| 04/19/2007 | WO2007042816A1 Benzoxazoles useful in the treatment of inflammation |
| 04/19/2007 | WO2007042786A2 4 -heteroaryl pyrimidine derivatives and use thereof as protein kinase inhibitors |
| 04/19/2007 | WO2007042602A1 Method for treating or preventing ischemia reperfusion injury or multi-organ failure |
| 04/19/2007 | WO2007042240A1 Quaternary alpha-aminocarboxamide derivatives as modulators of voltage-gated sodium channels |
| 04/19/2007 | WO2007009233A3 Peptide-based cytokine vaccines in the treatment of autoimmune and inflammatory diseases |
| 04/19/2007 | WO2007003422A9 Crystalline forms of macrolide compounds endowed with antiinflammatory activity |
| 04/19/2007 | WO2006105741B1 Topical pharmaceutical formulation containing nimesulide |
| 04/19/2007 | WO2006047492A3 Substituted nitrogen-containing heterocycles as vanilloid receptor ligands and their uses as medicament |
| 04/19/2007 | WO2006012779A8 Wikstroemia indeca extract their production and use in the production of anti-inflammatory pharmaceutical |
| 04/19/2007 | US20070088085 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands |
| 04/19/2007 | US20070088068 E-series of prostaglandin (EP) receptors; reducing [4-(4,9-dipropoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl)phenyl]acetate to form [[4-(4,9-dipropoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl) phenyl]acetic acid |
| 04/19/2007 | US20070088033 Diaryl Substituted Pyridinones |
| 04/19/2007 | US20070088027 Carboxylic acid derivatives and pharmaceutical compositions comprising the same as an active ingredient |
| 04/19/2007 | US20070088024 Active substance combination comprising a carbinol combined to at least an NSAID |
| 04/19/2007 | US20070088020 Agonists to a cannabinoid type 2 receptor; antiinflammatory agents; immunosuppressants; nephritis |
| 04/19/2007 | US20070088008 treating psoriasis with e.g. 19-nor-2beta-ethyl-1alpha,25-dihydroxyvitamin D3 |
| 04/19/2007 | US20070088003 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 04/19/2007 | US20070087970 Use of C-reactive protein to treat immune complex-mediated renal disease |
| 04/19/2007 | US20070087342 Secreted proteins |
| 04/19/2007 | US20070086993 Use of modified lysozyme c to prepare medicinal compositions for the treatment of some serious diseases |
| 04/19/2007 | DE102005034974A1 Salz von Dimethylaminomethyl-phenyl-cyclohexan und dessen kristalline Formen Salt of dimethylaminomethyl-phenyl-cyclohexane, and its crystalline forms |
| 04/19/2007 | CA2625763A1 Quaternary alpha-aminocarboxamide derivatives as modulators of voltage-gated sodium channels |
| 04/19/2007 | CA2625055A1 Novel dihydropseudoerythromycin derivatives |
| 04/19/2007 | CA2625042A1 Iontophoretic preparation for treatment of breast cancer and/or mastitis |
| 04/19/2007 | CA2623518A1 Method for treating or preventing ischemia reperfusion injury or multi-organ failure |
| 04/19/2007 | CA2623327A1 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same |
| 04/19/2007 | CA2620899A1 Benzoxazoles useful in the treatment of inflammation |
| 04/19/2007 | CA2620363A1 Naphthalene-disulfonamides useful for the treatment of inflammation |
| 04/18/2007 | EP1775305A2 6.Alpha.,9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl) oxy]-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothiotic acid s-fluoromethyl ester as an anti-inflammatory agent |
| 04/18/2007 | EP1775286A1 Novel anandamide amidase inhibitors as analgesic agents |
| 04/18/2007 | EP1775283A1 3-aminobenamide compound and vanilloid receptor 1 (vr1) activity inhibitor |
| 04/18/2007 | EP1774977A2 Genetically engineered bleb vaccine |
| 04/18/2007 | EP1773782A1 Derivatives of pyrazoline, procedure for obtaining them and use thereof as therapeutic agents |
| 04/18/2007 | EP1773779A1 Nicotinic receptor agonists for the treatment of inflammatory diseases |
| 04/18/2007 | EP1773396A1 Compositions for treatment of inflammation and pain using a combination of a cox-2 selective inhibitor and a ltb4 receptor antagonist |
| 04/18/2007 | EP1773375A1 Netrin-related compositions and uses |
| 04/18/2007 | EP1773340A2 Pharmaceutical composition of (+)-erythro-mefloquine and its use in the treatment of an inflammatory condition |
| 04/18/2007 | EP1583531B1 Heteroaryl-substituted pyrrolo[2, 3- b]pyridine derivatives as crf receptor antagonists |
| 04/18/2007 | EP1553949B1 Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors |
| 04/18/2007 | EP1476438B1 Oxa- and thiadiazoles and their use as metalloproteinase inhibitors |
| 04/18/2007 | EP1458386B1 Aroyl pyrrole heteroeryl and methanols useful for treating a central nervous system disorder |
| 04/18/2007 | EP1435976B1 Pharmaceutical composition comprising chito-oligomers |
| 04/18/2007 | EP1411970B1 Use of sarp-1 for the treatment and/or prevention of scleroderma |
| 04/18/2007 | EP1401479B1 Detection and therapy of vulnerable plaque with photodynamic compounds |
| 04/18/2007 | EP1394161B1 L-ascorbic acid-2-o-maleic acid-a-tocopherol diester 1-propanol adduct and process for producing the same |
| 04/18/2007 | EP1354590B1 Glucosamine or mannosamine in combination with trehalose against articular failure |
| 04/18/2007 | EP1352063B1 Receptor nucleic acids and polypeptides |
| 04/18/2007 | EP1345918B1 1,5 benzothiazepines and their use as antihyperlipidemics |
| 04/18/2007 | EP1326613B2 Use of substituted imidazo 1,2-a|pyridine-, imidazo ¬1,2-a|pyrimidine and imidazo ¬1,2-a|pyrazine-3-yl-amine derivatives for producing nos-inhibiting medicaments |
| 04/18/2007 | EP1227812B1 Topical nasal treatment using desloratadine and mometasone furoate |
| 04/18/2007 | EP1192261B1 22025, a novel human cyclic nucleotide phosphodiesterase |
| 04/18/2007 | EP1153125B1 Deglycosylated kringle 1-5 region fragments of plasminogen and methods of use |
| 04/18/2007 | EP1024835B1 J-chain and analogues as epithelial cell targeting conjugates |
| 04/18/2007 | CN1950375A Glucocorticoid receptor modulator compounds and methods- utility |
| 04/18/2007 | CN1950343A Basic amine compound and use thereof |
| 04/18/2007 | CN1950333A Substituted methyl aryl or heteroaryl amide compounds |
| 04/18/2007 | CN1950323A Crth2受体拮抗剂 Crth2 receptor antagonist |
| 04/18/2007 | CN1948343A Tetravalence single chain antibody of p53 tetra polymerized structure domain |
| 04/18/2007 | CN1948332A Glycyrrhetinic acid-30-acylamide derivatives and its use |
| 04/18/2007 | CN1948275A Verakanol Mannich alkali derivative, its preparation method and use |
| 04/18/2007 | CN1947772A Medicine prepn. for treating synovitis and synovial capsule cystis |
| 04/18/2007 | CN1947758A Medicine composition for treating rheumatosis and heumatism |
| 04/18/2007 | CN1947756A Formula of seven herbs medicine composition for relieving internal heat and invigorating blood circulation, its prepn. process and use |
| 04/18/2007 | CN1947755A Application of Malus asiatica composition for preparing medicines to treat women's diseases |
| 04/18/2007 | CN1947735A Medicine composition contg. isatis root and scutellariae glucoside |
| 04/18/2007 | CN1947733A Soft capsule prepn. contg. Sarcandra glaber, and its prepn. method |
| 04/18/2007 | CN1947717A Method for treating neuronal and non-neuronal pain |
| 04/18/2007 | CN1947706A Slow-release, controlled-release prepn. contg. chlortenozicam |
| 04/18/2007 | CN1947704A Medicinal water-soluble compositions contg. 20(R)-ginsenoside (Rg3), and its prepn. method |
| 04/18/2007 | CN1947700A Sustained release Brufen having magnetic super-molecular inserting layer structure and its prpen. method |
| 04/18/2007 | CN1947695A Method for producing black mud by using sea salt as raw material |